HopeStage
Back to all studies
WithdrawnNCT02233829

Dopamine Rhythms in Health and Addiction

Medication studyAges 21–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 55 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 23, 2024
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Radiation
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT02233829
Official title
Show the full official title

Dopamine Rhythms in Health and Addiction

Recruitment & locations

Withdrawn

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Brain Dopamine Reactivity.

Who can participate?

Listed age limits: 21 years to 55 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies